We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYNH
651
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-3,342,622
Closed -$141M
ICNC
652
DELISTED
Iconic Sports Acquisition Corp.
ICNC
-462,203
Closed -$4.92M
RETA
653
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-16,000
Closed -$133K
RETA
654
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-5,000
Closed -$510K
GFGD
655
DELISTED
The Growth for Good Acquisition Corporation Class A Ordinary Shares
GFGD
-453,158
Closed -$4.73M
DBTX
656
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
-199,200
Closed -$767K
CHEAW
657
DELISTED
Chenghe Acquisition Co. Warrant
CHEAW
-222,541
Closed -$12.4K
MBSC
658
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
-369,763
Closed -$3.86M
UTAA
659
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
-498,474
Closed -$5.27M
PIAI
660
DELISTED
Prime Impact Acquisition I
PIAI
-437,286
Closed -$4.67M
BKI
661
DELISTED
Black Knight, Inc. Common Stock
BKI
-16,329
Closed -$975K
NUVA
662
DELISTED
NuVasive, Inc.
NUVA
-941,845
Closed -$39.2M
FOCS
663
DELISTED
Focus Financial Partners Inc. Class A
FOCS
-2,775,549
Closed -$146M
FGMC
664
DELISTED
FG Merger Corp. Common Stock
FGMC
-222,542
Closed -$2.35M
ZING
665
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
-503,225
Closed -$5.25M
ARNC
666
DELISTED
Arconic Corporation
ARNC
-112,720
Closed -$3.33M
APMI
667
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
-231,102
Closed -$2.38M
AFTR.WS
668
DELISTED
AfterNext HealthTech Acquisition Corp Warrants
AFTR.WS
-678,553
Closed -$59.6K
AFTR
669
DELISTED
AfterNext HealthTech Acquisition Corp
AFTR
-1,395,656
Closed -$14.5M
CPAA
670
DELISTED
Conyers Park III Acquisition Corp. Class A Common Stock
CPAA
-2,867,097
Closed -$29.3M
CPAAW
671
DELISTED
Conyers Park III Acquisition Corp. Warrants
CPAAW
-979,817
Closed -$44.1K
DICE
672
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
-1,075,000
Closed -$49.9M
PDCE
673
DELISTED
PDC Energy, Inc.
PDCE
-3,101,445
Closed -$221M
ARBGW
674
DELISTED
Aequi Acquisition Corp warrants
ARBGW
-153,405
Closed -$4.68K
UNVR
675
DELISTED
Univar Solutions Inc.
UNVR
-6,121,961
Closed -$219M

Similar funds

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.